Ketamine Prevent POCD
- Registration Number
- NCT02220400
- Lead Sponsor
- RenJi Hospital
- Brief Summary
Previous study demonstrated that neuroinflammation induced by surgery is the main cause of the postoperative cognitive dysfunction. As an agonist of NMDA receptor, ketamine is proved to be an anti-inflammation agent. In present study investigators hypothesized that low dose ketamine would prevent the cognition decline after orthopedic surgery in aged patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 484
- Elder than 60
- Easily communicated with Chinese
- Selected to kneel or hip replacement
- Agree to take part into this clinical trail
- Existing cerebral disease, or have a history of neurological and psychiatric disease including AD, stroke and psychosis
- Existing cognitive impairment as evidenced by Mini-Mental State Examination scores below 24
- Several audition or vision disorder
- Preoperative systolic Blood pressure over 190mmHg or diastolic pressure >100mmHg
- Existing a history of hyperthyroidism
- Patient with glaucoma
- Unwillingness to comply with the protocol or procedures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ketamine Ketamine Ketamine infusion group
- Primary Outcome Measures
Name Time Method Short-term cognitive changes after surgery The day before surgery and 7 days after surgery (or before leave hospital) Investigators would use mini-mental state examination(MMSE), Visual reproduction test,digit symbol,digit span,color trail test and Stroop color and word test for measuring the short-term cognitive changes of patients after surgery.
Long-term cognitive changes after surgery The day before surgery and 2 months after surgery Investigators would use mini-mental state examination(MMSE), Visual reproduction test,digit symbol,digit span,color trail test and Stroop color and word test for measuring the long-term cognitive changes of patients after surgery.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Shanghai Tongji Hospital
🇨🇳Shanghai, Shanghai, China
Renji Hospital, School of Medicine, Shanghai Jiaotong University
🇨🇳Shanghai, Shanghai, China
Shanghai Pudong New Area People's Hospital
🇨🇳Shanghai, Shanghai, China